Breaking
$6 Billion in Suspected SNAP Fraud Stopped by USDA Task Force✦54% of BBC News Audiences Rate It Impartial as Charter Review Looms✦Sexual Assaults Up 650% in Ceuta, Bladed-Weapon Incidents Rise from 23 to 268✦336 Police Contacts, 8 Deportation Attempts: Germany's 22-Year Removal Failure✦€213.7 Million: EPPO Indicts Suspect in Bulgarian Railway Fraud✦19 Witnesses, Zero Racism Charges: France Drops Anti-White Motive in Perotto Murder✦$6 Billion in Suspected SNAP Fraud Stopped by USDA Task Force✦54% of BBC News Audiences Rate It Impartial as Charter Review Looms✦Sexual Assaults Up 650% in Ceuta, Bladed-Weapon Incidents Rise from 23 to 268✦336 Police Contacts, 8 Deportation Attempts: Germany's 22-Year Removal Failure✦€213.7 Million: EPPO Indicts Suspect in Bulgarian Railway Fraud✦19 Witnesses, Zero Racism Charges: France Drops Anti-White Motive in Perotto Murder✦
Sunday, 22 November 2026Est. 2026

FRISIAN NEWS

The numbers behind the news

€153 Million: German Taxpayers Fund Vaccine Makers' Legal Defence in 863 Cases
Economy

€153 Million: German Taxpayers Fund Vaccine Makers' Legal Defence in 863 Cases

November 18, 2026 · Frisian News

Photo: Wikimedia Commons

The German federal government has paid €29.4 million to cover vaccine manufacturers' legal costs in 863 ongoing injury lawsuits since 2021, while claimants receive no matching support. A further €47.2 million is budgeted for lawyers in 2027, with €25.6 million per year planned through 2030.

English

863 lawsuits alleging COVID-19 vaccine injury are working through German courts. The federal government is funding the manufacturers' defence in every one of them. It funds the plaintiffs in none.

Since early 2021, Berlin has paid €29.4 million to cover vaccine manufacturers' legal bills, according to a government answer to a parliamentary question from the AfD faction published on 16 November. The plaintiffs receive no matching support. Asked directly whether the federal government also covers claimant costs in these proceedings, the government replied with a single word: "No."

The annual bill has accelerated sharply. ZEPAI, the Centre for Pandemic Vaccines and Therapeutics housed within the Paul Ehrlich Institute, recorded manufacturer lawyer invoices of €4.7 million in 2023, rising to €8 million in 2024 and €15.8 million in 2025. By the end of June 2026, another €500,000 had been added. ZEPAI also held €15.16 million in unpaid invoices as of that date, withheld on grounds of "economy and thrift". Whether those bills will ever be settled remains open.

Attorney Tobias Ulbrich, whose firm represents around 2,500 claimants seeking compensation from vaccine makers, told Multipolar Magazine that manufacturers routinely dispatch two lawyers to each court date and have shown no willingness to settle. Under Germany's statutory fees schedule, 1,118 cases would have generated roughly €2 million to €3 million in fees, he estimated. The government paid €13.2 million for those same cases. The gap implies hourly billing. The government refuses to disclose the rates, citing trade secrets.

Future costs dwarf what has already been paid. The 2027 federal budget allocates roughly €47.2 million under a line item labelled "subsidies for the central procurement of SARS-CoV-2 vaccines," a title the Federal Court of Auditors has found misleading since the money no longer buys vaccines but covers legal costs. For each of the years 2028 to 2030, the financial plan sets aside a further €25.6 million. The government has set no upper limit on its exposure.

The obligation traces back to the EU vaccine procurement contracts. The Pfizer/BioNTech agreement, signed by the European Commission on 11 November 2020, contained an indemnity clause under which member states agreed to reimburse manufacturers for "reasonable direct external legal costs" arising from claims linked to vaccine use. Germany signed. The relevant clauses remain classified. The government told parliament it has not asked the European Commission to release them.

The case count is rising without sign of slowing. One lawsuit was filed in 2021. That number climbed to 53 in 2022, 323 in 2023 and 399 in 2024. By 30 June 2026, 863 cases remained pending, all citing health damage from SARS-CoV-2 vaccination, according to ZEPAI data. A further 2,936 liability reports had been lodged with ZEPAI by 16 June 2026, some not yet in court.

Germany's Federal Court of Justice (BGH) has started to shift the legal terrain. In a ruling reported by Handelsblatt, the BGH found that legal expenses insurers cannot refuse coverage to claimants suing vaccine makers solely because a vaccine had a positive benefit-risk profile, overturning a Düsseldorf appeals court decision. Courts in Ravensburg, Dresden and Bamberg have issued partial rulings ordering manufacturers to disclose pharmacovigilance data, according to Multipolar Magazine. Attorney Ulbrich expects those disclosure orders to precede final judgments in favour of the injured.

The contracts that created this arrangement remain classified. The bills do not.


Published November 18, 2026 · Frisian News